Insulet Corp
PODD: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|Qr | LOCK|?kPQ< | LOCK|g&rPR?<p |
Insulet Earnings: Slower Growth Fails to Diminish Strong Fundamentals in 2024
Insulet increased fourth-quarter 2024 revenue by 17% in constant currency, hampered by an unfavorable comparison with the prior-year period. However, adjusted for these distributor distortions, US Omnipod revenue rose 26%, reflecting solid underlying demand.
